To enhance your user experience on our website, this site uses cookies.
If you continue to browse, you accept the use of cookies on our site.
See our Privacy Policy
for more information.
Glyco-engineered expression platform is an important strategy to improve biopharmaceuticals. A better control of the factors leading to glycan heterogeneity will simplify the process of production of recombinant glycoprotein with less variation in terms of glycosylation.